Breaking News on Laboratory EquipmentDaily
Thursday 17 January 2008
Forward to a colleague |
|
|
| Breaking News on Laboratory Equipment |
||
|
||
| Daily
Thursday 17 January 2008 |
Forward to a colleague |
|
|
Access Full Stories  EC launches major pharma industry probeThe European Commission has launched an investigation into the entire European pharmaceutical sector, with surprise raids on a number of manufacturers in a bid to unearth any evidence of foul-play hampering the... Read Industry news in brief - 3 LabTechnologist.com brings you a round up of recent industry news, with developments at Activotec, Protagen, Caprotec Bioanalytics and PANalytical... Read Preclinical news in brief In this week's review of activity within the preclinical research services arena, news has emerged involving Galapagos, Argenta Discovery and ChemDiv... Read Wyeth site rescued by new start-up firm Wyeth's manufacturing facility in Rouses Point, New York, has been spared the scrap heap, with yesterday's announcement that new pharma player Akrimax has bought up the beleaguered site... Read Buffer cocktail maintains pH when freezing Scientists have discovered a technique that can ensure lab samples stay at the right pH, even when frozen and the discovery could bring into doubt previously published research... Read |
|
|||||||||||||||
All News Headlines for: January | December | November |
|||||||||||||||||
|
Related Industry News Pharmaceutical manufacturing: people on the move Neurocrine, Mersana Therapeutics, ISPE and Nastech have all had people on the move in the world of pharmaceutical manufacturing... Read Sartorius Stedim inks deal, closes plant Processing specialist Sartorius Stedim Biotech today announced a cooperation and supply deal with systems manufacturing firm Paul Mueller Company for the US market, with a production facility in Pennsylvania set... Read Thirst for outsourcing fuelling product recalls Product recalls in the UK due to health and safety concerns have shot up to their highest level, with the rise in outsourcing to China fingerpointed for much of the blame... Read Novo drops inhaled insulin plans in post-Exubera fallout Mere months after Pfizer's high profile exit from the inhaled insulin market in the wake of Exubera's much publicised market failure, Novo Nordisk announced late last night that it, too, has decided to halt development... Read
|
|||||||||||||||||
|
|
|
|||
| Forward to a colleague |
|||||
|
To continue to receive this newsletter in your inbox, please add newsletter@LabTechnologist.com to your address book |
|
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2008 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||
